In the latest trading session, 0.7 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.87. With the company’s most recent per share price at $0.65 changed hands at -$0.03 or -4.35% at last look, the market valuation stands at $3.83M. PSTV’s current price is a discount, trading about -310.77% off its 52-week high of $2.67. The share price had its 52-week low at $0.24, which suggests the last value was 63.08% up since then. When we look at Plus Therapeutics Inc’s average trading volume, we note the 10-day average is 50.8 million shares, with the 3-month average coming to 8.53 million.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Instantly PSTV was in red as seen in intraday trades today. With action -48.87%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -43.54%, with the 5-day performance at -48.87% in the red. However, in the 30-day time frame, Plus Therapeutics Inc (NASDAQ:PSTV) is -45.89% down. Looking at the short shares, we see there were 0.14 million shares sold at short interest cover period of 1.23 days.
Plus Therapeutics Inc (PSTV) estimates and forecasts
Year-over-year growth is forecast to reach 10.21% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 1.19M. 3 analysts are of the opinion that Plus Therapeutics Inc’s revenue for the current quarter will be 1.73M. The company’s revenue for the corresponding quarters a year ago was 1.31M and 1.68M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -9.18%. The estimates for the next quarter sales put growth at 3.36%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 68.20%. The 2025 estimates are for Plus Therapeutics Inc earnings to increase by 54.36%, but the outlook for the next 5-year period is at 29.07% per year.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.34% of Plus Therapeutics Inc shares while 11.50% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 11.78%.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 34.96 shares estimated at $22480.0 under it, the former controlled 0.59% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.55% of the shares, roughly 32.54 shares worth around $20927.0.
